2020 Luminaries

The HBA Luminary award was introduced in 2014 as part of the HBA’s 25th anniversary of the Woman of the Year (WOTY). This year, the HBA is proud to recognize 71 senior women, identified by their Corporate Partner companies, who serve as a role in their company, actively mentor and sponsor others, help advance other women’s careers and exhibit dedication to the healthcare industry. These luminary leaders have more than 20 years of professional industry experience. 

Charlotte Allerton, SVP, head, medicine design    
Pfizer Inc.

Linda Armstrong, global head, respiratory development unit    
Novartis Pharmaceuticals Corporation

Anne Arvizu, CEO and medical affairs advisor    
RxER Communications Corp

Kimberly Baldwin, VP, franchise head, neuroscience business unit    
Ipsen Biopharmaceuticals

Kathy Bardeen, VP, product delivery and consulting    
LexisNexis Risk Solutions Health Care

Bridget Bilodeau, senior director, global customer service    
Integra LifeSciences

Tracy Blackwell, creative lead    
Fingerpaint Marketing, Inc.

Lisa Blevins, global head, organizational development    
Sanofi Genzyme

Jennifer Breuer, partner, deputy co-leader, healthcare practice group, steering committee, Faegre Drinker Women
Faegre Drinker Biddle & Reath LLP

Lekeshia Bush, registered manager onsites    
Walgreens Boots Alliance

Tara Capalbo, VP, marketing, neurosciences and urology    
Allergan

Andrea Caruso, SVP, corporate business development
Integra LifeSciences

Marion Chaplick, global client leader    
Publicis Health

Laura Chenoweth, deputy general counsel    
Pfizer Inc.

Laura Clague, CFO    
Retrophin

Angel Cooper, VP, global portfolio and program management    
Mallinckrodt Pharmaceuticals

Gwen Cummings, executive director, finance and Amgen capability center site lead    
Amgen Inc.

Anne Marie Dallaire, AVP, head, boosters, travel and endemic franchises    
Sanofi Pasteur

Emily Doyle, chief HR officer    
Strongbridge Biopharma plc

Libby Driscoll, VP, US neuroscience    
Eli Lilly and Company

Gina Dunsmuir, VP, associate general counsel    
Ortho Clinical Diagnostics

Melissa Easy, VP, head, trial design, planning and site engagement    
IQVIA

Nancy Fetrow, VP, R&D project management    
CSL Behring

Denise Flanagan, executive director, regulatory affairs, CMC    
Shionogi Inc.

Elizabeth Forminard, WW VP, general counsel pharmaceuticals group    
Johnson & Johnson

Nancy Forrest, VP, development and commercial alliances    
Bristol-Myers Squibb Company

Teri Foy, SVP, immuno-oncology and cell therapy    
Bristol-Myers Squibb Company

Mary-Lynn Fulton, executive director, clinical trial management    
Vertex Pharmaceuticals

Jill German, head 
Roche Tissue Diagnostics, Roche Molecular Solutions

Melanie Gloria, SVP, R&D operations    
Horizon Therapeutics

Suzanne Greenwood, SVP, commercial solutions    
EVERSANA

Adriana Guana, VP, medical strategy and scientific affairs    
LEO Pharma Inc.

Ann Hartry, VP, evidence strategy and communication    
Lundbeck

Laurie Hill, VP, intellectual property    
Genentech, Inc.

Leigh Householder, EVP, managing director, innovation and insight, Syneos Health Communications    
Syneos Health

Peyton Howell, chief commercial and strategy officer    
Parexel

Amy Inzanti, group SVP, strategy, research and insights    
Marina Maher Communications LLC

Nicola Kayel, VP, marketing, Salix    
Bausch Health

Marie Keeley, VP, biopharma solutions    
Baxter International Inc. 

Paige Kilian, CMO
Inovalon

Ellen Kondracki, VP, sustainability and environment, health and safety    
BD

Marni Kottle, VP, public affairs    
Gilead Sciences

Bari Kowal, VP, global head, clinical project management and operations     
Regeneron Pharmaceuticals, Inc.

Sora Lee, VP and general manager Korea, clinical solutions    
Syneos Health

Georgia Lehoczky, regional healthcare director, pharmacy operations    
Walgreens Boots Alliance

Linda MacDonald, VP and COO    
Avanir Pharmaceuticals

Ashley Magargee, global head, business insights, operations and established products    
Roche (F. Hoffmann - La Roche Ltd)

Kim Martin, VP, CNS sales    
Otsuka America Pharmaceutical, Inc.

Cynthia McDonald-Everett, VP, global value access and pricing    
Seattle Genetics, Inc.

Susan Mitmesser, VP, science and technology    
Pharmavite LLC

Mary Jo Mullen, VP, managed care    
AMAG Pharmaceuticals, Inc.

Anne Neal, VP, product management assoc    
Cognizant Technology Solutions

Anu Osinusi, executive director, clinical research    
Gilead Sciences

Amy Park, VP, pharma partnerships    
Doximity, Inc.

Audrey Pezzuti, CIO    
Health & Wellness Partners, LLC

Leslie Pott,  VP, communications    
Novartis Pharmaceuticals Corporation

Caroline Redeker, SVP, corporate development    
Advanced Clinical

Kristen Reimers, SVP, specialty clinical solutions    
Magellan Rx Management

Stephanie Revish, VP, finance    
Cardinal Health

Caroline Roan, VP, corporate responsibility    
Pfizer Inc.

Jackie Ryan, executive director, enterprise financial management customer success
athenahealth

Christina Scully, VP, internal manufacturing and supply chain quality    
Bristol-Myers Squibb Company

Neha Sheth, executive director, risk management and benefit risk    
Astellas Pharma US, Inc.

Wendy Short Bartie, associate VP    
Merck & Co., Inc.

Soo Son, director, business transformation    
GlaxoSmithKline

Wendy Stein, SVP and site head, Indianapolis, GM, Roche Diagnostics operations    
Roche Diagnostics

Mary Varghese Presti, VP, offerings, life sciences    
IBM Watson Health

Sepideh Varon, VP, global health economics and outcomes research    
Allergan

Bonnie Welsch, COO    
Health & Wellness Partners, LLC

Dianne Yurek, VP, corporate marketing    
Medidata, a Dassault Systèmes Company

Martine Zimmermann, SVP, global head, regulatory affairs    
Alexion Pharmaceuticals, Inc.